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Abstract
Objective: The present study evaluated the effect of systemic injection of the CRF1 receptor
antagonist R121919, the corticosterone synthesis inhibitor metyrapone and central amygdala
(CeA) injections of the nonselective CRF antagonist D-Phe-CRF(12–41) in rats in which binge eating
was evoked by stress and cycles of food restriction.
Method: Female rats were subjected or not to repeated cycles of regular chow food restriction/ad
libitum feeding during which they were also given limited access (2 h) to palatable food. On the
test day, rats were either exposed or not to the sight of the palatable food for 15 min without
allowing access, before assessing food consumption.
Results: Systemic injections of R121919, but not of the metyrapone, blocked binge-like eating
behavior. Restricted and stressed rats showed up-regulation of crh1 receptor mRNA signal in the
bed nucleus of the stria terminalis and CeA but not in basolateral amygdala (BLA) or in the para-
ventricular nucleus. Injection D-Phe-CRF(12–41) in CeA but not in the BLA-blocked binge-like
eating behavior.
Discussion: These findings demonstrate that extra-hypothalamic CRF1 receptors, rather than
those involved in endocrine functions, are involved in binge eating and the crucial role of CRF
receptors in CeA. CRF1 receptor antagonism may represent a novel pharmacological treatment for
binge-related eating disorders.
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1 | INTRODUCTION
Binge-eating episodes represent a core behavioral feature of binge-
eating disorder (BED), bulimia nervosa, and binge/purge subtype
anorexia nervosa (American Psychiatric Association, 2013). Epi-
sodes of binge-eating in humans are characterized by compulsive,
nonhomeostatic consumption of an unusually large quantity of
highly palatable food in a short period of time. Binge eating is also
an additional feature of obese individuals, significantly contributing
to their high caloric intake and finally being overweight (Hudson,
Hiripi, Pope, & Kessler, 2007; Swanson, Crow, Le Grange,
Swendsen, & Merikangas, 2011). Even in the absence of hunger,
some subjects exhibit episodes of rapid eating beyond satiation
accompanied by an uncontrollable urge to obtain and consume
food. This condition resembles behavioral phenomena described in
drug dependence and similarities between binge eating and addic-
tion have been proposed (Avena, 2011; Avena, Bocarsly, Hoebel, &
Gold, 2011; Corwin & Grigson, 2009; Cottone et al., 2009; D’Ad-
dario et al., 2014; Johnson & Kenny, 2010; Volkow, Wang, Fowler,
Tomasi, & Baler, 2012).
A large body of evidence suggests that dieting, stress, and negative
affect represent possible triggers of binge eating in patients suffering
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from BED or bulimia nervosa (Freeman & Gil, 2004). Indeed, dieting
periods are a common finding in the history of people with binge-
eating disorder, although hunger per se appears to be insufficient to
induce binge eating in the absence of stress and negative affective
state (Polivy, Zeitlin, Herman, & Beal, 1994). The important role of
stress in the etiology of binge eating is emphasized by the finding that
obese individuals with BED exhibit activation of the hypothalamic–
pituitary–adrenal (HPA) axis, and their cortisol levels are higher in com-
parison to those of obese individuals without BED (Gluck, Geliebter,
Hung, & Yahav, 2004). Moreover, higher blood cortisol levels in
response to stress predict greater intake of sweets (Epel, Lapidus, McE-
wen, & Brownell, 2001) and salivary cortisol levels are positively corre-
lated with binge eating severity (Coutinho, Moreira, Spagnol, &
Appolinario, 2007). Thus the increase of corticosterone levels represent
a hormonal marker of binge eating induced by cyclic food restrictions
and stress (Artiga et al., 2007; Cifani et al., 2010; Cifani, Polidori,
Melotto, Ciccocioppo, & Massi, 2009) and palatable food intake has
been shown to blunt activation of the HPA axis (Christiansen, Dekloet,
Ulrich-Lai, & Herman, 2011; Kinzig, Hargrave, & Honors, 2008) sug-
gesting that it may represent a kind of self-medication in conditions of
stress. The CRF system initiates the neuroendocrine response to stress
via the HPA axis, and coordinates several behaviors via actions on extra
hypothalamic neural substrates. At extra hypothalamic sites, including
the central amygdala (CeA) and the basolateral amygdala (BLA), CRF
coordinates the affective reactions to stress (Gray, 1993; Wang et al.,
2011). CRF1 is the most abundantly expressed CRF receptor in the
brain and high density has been reported in the hypothalamus, in the
ventral tegmental area, amygdala, and various cortical structures.
Expression of CRF2 receptors is more restricted and is primarily
detected in the hypothalamus, dorsal raphe, and lateral septum (Bale &
Vale, 2004; Fekete & Zorrilla, 2007; Schank, Ryabinin, Giardino, Cicco-
cioppo, & Heilig, 2012).
It is well known the involvement of CRF system on CRF-induced
anorexia (Cabanac & Richard, 1995; Ciccocioppo et al., 2002; Cicco-
cioppo, Martin-Fardon, Weiss, & Massi, 2001; Heinrichs et al., 1996;
Heinrichs, Li, & Iyengar, 2001; Heinrichs & Richard, 1999; Richard, Lin,
& Timofeeva, 2002) and stress-induced anorexia (Epstein et al., 2016;
Harris, 2017; Stengel & Tache, 2014), or hypophagia for palatable food
(Cottone et al., 2009; Fedeli et al., 2009; Iemolo et al., 2013; Zorrilla
et al., 2004).
In particular CRF1 receptor antagonists have been reported to
reduce stress-induced palatable food-seeking (Ghitza, Gray, Epstein,
Rice, & Shaham, 2006) and to reduce withdrawal symptoms in condi-
tions of intermittent access to palatable food (Cottone et al., 2009) in
rats, and also to reduce palatable food craving and eating in restrained
eaters (Epstein et al., 2016).
We recently reported that systemic injections of the CRF1 recep-
tor antagonist R121919 and bed nucleus of the stria terminalis (BNST)
injections of the CRF receptor antagonist D-Phe-CRF(12–41) decreased
frustration stress-induced binge eating in rats with a history of food
restriction (Micioni Di Bonaventura et al., 2014).
These data suggest the possibility that CRF-induced modulation of
binge eating is not only linked to peripheral corticosteroid hormonal
release subsequent to HPA activation but also with the involvement of
extra hypothalamic mechanisms.
To explore this possibility, we used an animal model in female rats,
in which binge-like eating was elicited by a history of cyclic food
restriction and an acute frustration stress (exposure to a familiar palata-
ble food, without being allowed access to it). This stress procedure has
face validity as a model of the putative contributions of dieting and
negative-valence states, to binge eating in humans (Association, 2013;
Mathes, Brownley, Mo, & Bulik, 2009; Sanislow et al., 2010; Treasure,
Claudino, & Zucker, 2010; Vannucci et al., 2015). Considering the high
prevalence of binge eating in women (Hudson et al., 2007; Swanson
et al., 2011), we used female rats, in which binge-like eating behavior
varies across the estrus cycle (Alboni et al., 2017; Micioni Di Bonaven-
tura et al., 2017), similarly to women (Culbert, Racine, & Klump, 2016;
Edler, Lipson, & Keel, 2007; Klump et al., 2013; Schoofs, Chen, Braunig,
Stamm, & Kruger, 2011) and this result increases the validity of the
model that can be used in translational studies of the mechanism of
binge-eating behavior.
Here, using this rat model, we studied the role of CRF system in
stress versus nonstress conditions, in food restricted versus nonfood
restricted conditions and both stress plus restriction that induce binge
eating. We investigate the effect of exogenous corticosterone adminis-
tration and metyrapone-induced corticosterone synthesis inhibition
and the effect of systemic injection of the selective CRF1 antagonist
R121919. Finally, guided by the analysis of crh1 receptor (crhr1)
mRNA transcripts in the brain, using the nonselective CRF1/2 pepti-
dergic antagonist D-Phe-CRF(12–41), we evaluated the effect of block-
ade of CRF receptors in the CeA and the BLA on binge eating.
2 | METHOD
2.1 | Experiment 1. Effect of the CRF1 receptor
antagonist R121919 or metyrapone on binge eating
We determined the effect of systemic injection of R121919 on frustra-
tion stress-induced binge-like eating to compare its effect with that of
metyrapone, tested in the same rats.
We used 108 female Sprague-Dawley rats that were divided into
12 groups (n59 per group) in a 2 (history of intermittent food restric-
tion: no, yes) 3 2 (stress during testing: no, yes) 3 3 (R121919 dose: 0,
10, 20 mg/kg) factorial design. We injected the rats with vehicle or
R121919, 60 min before of the 2 h palatable food access.
These rats were exposed (or not exposed) for 24 days (d) to three
8-d cycles of food restriction (66% of chow intake on d 1–4 and free
feeding on d 5–8 of each cycle) during which they were given access to
palatable food (prepared by mixing of Nutella (Ferrero, Italy) chocolate-
hazelnut cream, chow, and water as described in Supporting Informa-
tion Methods) for 2 h during the light cycle on d 5–6 and 13–14 of the
first two cycles (total of four exposures). On the binge intake test day,
we assessed palatable food intake for 2 h immediately after exposure
or not to frustration stress (Figure 1a). This stress procedure was
adopted to generate a mild stressful condition triggered by the view of
palatable food and causes a significant increase in serum corticosterone
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levels (Cifani et al., 2010; Cifani, Di Bonaventura, Ciccocioppo, & Massi,
2013; Micioni Di Bonaventura, Vitale, Massi, & Cifani, 2012).
In previous studies we observed that in the estrous phase of the
ovarian cycle, female rats do not exhibit binge eating using our model
(Alboni et al., 2017; Micioni Di Bonaventura et al., 2017) while in all
other three phases, the rats exhibit binge eating without significant dif-
ferences in intensity. Therefore, to control for the estrous cycle, imme-
diately after the test on d 25, vaginal smears were collected and
analyzed under microscope by an experimenter blind to treatment con-
ditions. Data from rats in the estrous phase were not included in the
statistical analysis.
As reported in our previous studies (Cifani et al., 2009; Micioni Di
Bonaventura et al., 2013; Piccoli et al., 2016), after 1 d off at the end
of the first test, the same animals received an additional 8-d cycle: the
nonrestricted groups had 8 d of chow ad libitum, whereas the
restricted groups had 4 d chow restricted to 66% of the normal intake
followed by 4 d of chow ad libitum. In this additional cycle, all groups
did not have access to palatable food. The following day, the stressed
groups were exposed to stress while the nonstressed groups were not.
On the test day, 1 h before access to palatable food, rats were treated
i.p. with Metyrapone (0, 50, 100 mg/kg).
2.2 | Experiment 2. Effect of corticosterone on rats
with a history of repeated cycles of food restriction/
ad libitum feeding
To assess whether exogenous corticosterone, injected in rats submit-
ted to three cycles of food restriction but not exposed to stress evokes
binge eating, 63 female rats were used.
They were divided into two groups, matched for body weight and
daily food intake: (a) nonrestricted and not exposed to stress group
(n527); (b) restricted and not exposed to stress group (n527). A third
group (restricted and stressed rats, n59), treated only with vehicle,
was added to compare the binge-eating response to that of the other
groups treated with corticosterone.
Rats were submitted to three consecutive 8-d cycles followed by
the final test on d 25 as described in Experiment 1.
On the test day (d 25), nonstressed animals were divided into sub-
groups of nine rats and treated i.p. with corticosterone (2.5 or 5 mg/
kg), or its vehicle, 30 min before access to palatable food.
After 1 d off at the end of the first test, the same animals received
an additional 8-d cycle as described above. On the test day, animals
were divided into three subgroups of nine rats and treated i.p. with
corticosterone (10 or 15 mg/kg), or its vehicle, 30 min before access to
palatable food.
2.3 | Experiment 3. In situ hybridization analysis of
crhr1 mRNA transcripts in the BNST, CeA, BLA, and
paraventricular nucleus
For the in situ hybridization experiment, 36 rats were divided into four
groups (n59/group) in a 2 (history of intermittent food restriction: no,
yes) 3 2 (stress during testing: no, yes) factorial design.
These rats were exposed (or not exposed) for 24 d to three 8-d
cycles of food restriction. On the binge intake test day, they were
exposed or not to frustration stress as described above. On d 25, rats
were sacrificed by decapitation.
2.4 | Experiment 4. Effect of CeA and BLA injection of
D-phe-CRF(12–41) on binge eating
We determined the effect of CeA and BLA injections of the CRF recep-
tor antagonist D-Phe-CRF(12–41) on binge eating.
For CeA microinjection we used 32 rats that were divided into
four groups (n58/group). Two groups were not exposed to cycles of
food restriction and frustration stress and were tested for the effect of
D-Phe-CRF(12–41) (0, 300 ng/side) on palatable food intake during the
2 h test on d 25. Two other groups were exposed to three cycles of
food restriction and frustration stress and were tested for the effect of
D-Phe-CRF(12–41) (0, 300 ng/side) on stress-induced expression of
binge eating. We injected D-Phe-CRF(12– 41) 30 min before the 2 h pal-
atable food access (15 min before the beginning of the frustration
stress for the stressed groups).
For BLA microinjection we used another 32 rats divided into four
groups (n58/group); the experimental procedure was the same
described above for CeA microinjection experiment.
Additional methodological details are contained in Supporting
Information, Methods.
3 | RESULTS
3.1 | Experiment 1
As in our previous studies (Cifani et al., 2010; Cifani et al., 2009; Micioni
Di Bonaventura, Cifani, et al., 2012; Micioni Di Bonaventura, Vitale,
et al., 2012; Pucci et al., 2016), body weight of rats was reduced during
the 4 d of food restriction, but immediately afterwards the animals
increased their food intake and rapidly recovered their body weight to
levels of controls by the end of each cycle. On the test day body weight
of animals, as well as their food intake in the previous 24 h, were not
significantly different among the groups (data not shown).
Thirty-two rats (of the 108) were excluded from the analysis
because of estrous on the test day.
At 15 min, a three-way ANOVA, which included the between-
subjects factors of history of intermittent food restriction (no, yes),
stress during testing (no, yes), and R121919 dose (0, 10, 20 mg/kg),
showed a significant interaction among the three factors [F(2,64)53.5,
p< .05]. Post hoc test showed an increase of palatable food consump-
tion during the first 15 min of the feeding test on Day 25 (p< .01) (Fig-
ure 1b, left panel), only in vehicle rats with a history of intermittent
food restriction and frustration stress (binge-eating group). Post hoc
test revealed also that systemic injections of R121919 in restricted and
stressed rats decreased palatable food consumption during the first 15
min of the feeding test (p< .01) (Figure 1b, left panel). In contrast,
R121919 injections had no effect on palatable food intake in the other
three groups (p> .05).
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ANOVA of the 2 h cumulative palatable food showed a three-way
interaction (food restriction, stress, and R121919 dose) [F(2,64)53.3,
p< .05]. As shown in Figure 1b (right panel), the post hoc test revealed
that 2 h cumulative palatable food intake was significantly increased in
the vehicle restricted and stressed group in comparison to the other
vehicle groups (p< .01). Moreover, the post hoc test showed that the
FIGURE 1 Systemic injections of the CRF1 receptor antagonist R121919 but not metyrapone decreased frustration stress-induced binge
eating in rats with a history of intermittent food restriction. (a) Timeline of the experimental procedures for the food nonrestricted (top)
and restricted (bottom) rats. (b) Mean6SEM palatable food intake (kcal/kg) during the first 15 min (left) and the cumulative 2 h (right) test
session. *p< .05; **p< .01, different from the vehicle condition; #p< .05; ##p< .01, different from the other three vehicle groups. n56–8
per group. (c) Mean6SEM palatable food intake (kcal/kg) during the first 15 min (left) and the cumulative 2 h (right) test. #p< .05;
##p< .01, different from the nonrestricted and nonstressed group. n56–8 per group
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treatment with R121919 (20 mg/kg) significantly reduced palatable food
intake in restricted and stressed group (p< .01) (Figure 1b, right panel).
In the second test with metyrapone treatment, 31 female rats (of
the 108 used in the experiment) were excluded from the analysis
because of estrous on the test day.
At 15 min, overall ANOVA which included the between-subjects
factors of history of intermittent food restriction (no, yes), stress during
testing (no, yes), and metyrapone dose (0, 50, 100 mg/kg), showed a
significant interaction between food restriction and stress [F(1,66)5
33.7, p< .01]. As shown in Figure 1c (left panel), 15 min palatable food
consumption in vehicle rats with a history of food restriction, and
exposed to 15 min frustration stress was significantly higher in compar-
ison to the other vehicle groups. Systemic injections of metyrapone did
not reduce palatable food intake in any group of rats.
ANOVA of the 2 h cumulative palatable food showed a significant
interaction between food restriction and stress [F(1,66)514.8,
p< .01]. As shown in Figure 1c (right panel), 2 h cumulative palatable
food intake was significantly increased only in the vehicle restricted
and stressed group in comparison to the other vehicle groups. The
treatment with metyrapone did not affect feeding in any group.
3.2 | Experiment 2
Twenty rats (of the 88 used in the experiment) were excluded from the
analysis because of estrous on the test day.
The statistical analysis of the first 15 min palatable food intake,
which included the between-subjects factors of history of intermittent
food restriction (no, yes), and corticosterone dose (0, 2.5, 5.0 mg/kg),
did not show a significant interaction between two factors [F(6,99)5
0.5, p> .05] (Figure 2a, left panel).
ANOVA of the 2 h cumulative palatable food did not show a two-
way interaction (food restriction, and corticosterone dose) [F(2,33)5
0.13, p> .05] (Figure 2a, right panel).
After an additional food restriction/ad libitum feeding cycle, higher
doses of corticosterone (10, 20 mg/kg) also did not produce significant
interactions between the two factors during the first 15 min [F
(6,105)51.9, p> .05] (Figure 2b, left panel) or cumulatively through
the 2 h session [F(2,35)50.32, p> .05] (Figure 2b, right panel).
Overall ANOVA comparing the vehicle group (nonrestricted and
nonstressed; restricted and nonstressed; restricted and stressed)
showed a significant group interaction in the first experiment [15 min:
F(2,16)521.2, p< .01] [2 h: F(2,16)54.2, p< .05] and in the second
experiment [15 min: F(2,15)515.3, p< .01] [2 h: F(2,16)513.1,
p< .01]. Post hoc test showed that the palatable food intake of
restricted and stressed rats (binge-eating group) treated with vehicle
was significantly higher in comparison to the other two vehicle groups
both in the first test [15 min (p< .05) and cumulative 2 h (p< .01)] and
in the second test [15 min (p< .05) and cumulative 2 h (p< .01)].
3.3 | Experiment 3
For the in situ hybridization 12 rats were not used because of estrous
on the test day.
For crhr1 mRNA levels, overall two-way ANOVA with history
of intermittent food restriction (no, yes), and stress during testing
(no, yes) as between factors, showed a significant interaction in dor-
sal BNST [F(1,20)53.2, p< .05], but not in ventral BNST [F(1,20)5
2.9, p> .05]. Post hoc test showed that in dorsal BNST crhr1 mRNA
levels were significantly higher (p< .05) in restricted and stressed
rats compared to the nonrestricted and nonstressed rats (Figure
3a).
In the CeA overall ANOVA revealed also a significant interaction
between the two factors of history of intermittent food restriction
and stress [F(1,20)53.9, p< .05]. As shown in Figure 3c, post hoc
test revealed a higher level (p< .01) of crhr1 mRNA in restricted
and stressed rats compared to the nonrestricted and nonstressed
rats.
Two-way ANOVA showed that crhr1 mRNA levels in BLA
were significantly affected by frustration stress [F(1,20)514.5,
p< .01] but not by restriction [F(1,20)50.6, p> .05]. No interaction
between these two factors was detected [F(1,20)50.002, p> .05]
(Figure 3d).
Two-way ANOVA showed that crhr1 mRNA levels in paraventric-
ular nucleus (PVN) were not significantly affected by frustration stress
[F(1,20)51.4, p> .05] nor by restriction [F(1,20)50.08, p> .05]. No
significant interaction between these two factors was detected [F
(1,20)50.8, p> .05] (Figure 3e).
3.4 | Experiment 4
Fourteen female rats (of the 64 used in the experiment) were excluded
from the statistical analysis because of estrous on the test day.
After histological evaluation for correct cannula placement nine
(three were already excluded because in the estrous phase) of the 64
rats were excluded from the analysis because of placements outside
the CeA or BLA. Representative brains with correct cannula place-
ments in CeA and in BLA are shown in Supporting Information, Figure
S1.
The statistical analysis for microinjection in CeA, which included
the between-subjects factors of group condition (nonrestricted and
nonstressed and restricted and stressed groups) and D-Phe-CRF(12– 41)
dose (0, 300 ng/side), showed a significant interaction between the
two factors [F(1,19)57.5, p< .05], at 15 min.
ANOVA of the 2 h cumulative palatable food intake showed a
significant interaction between the two factors [F(1,19)54.9,
p< .05].
As shown in Figure 4, post hoc test revealed a significant
increase in palatable food consumption in the restricted and
stressed groups during the first 15 min (p< .01) and at the end of
the test (2 h cumulative food intake) (p< .05). Moreover, the treat-
ment with D-Phe-CRF(12–41) (300 ng/side) significantly reduced pal-
atable food intake only in restricted and stressed group at 15 min
(p< .01).
The statistical analysis for microinjection in BLA did not show a
significant interaction between the two factors (group condition, and
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D-Phe dose) at 15 min [F(1,17)50.2, p> .05] and 2 h [F(1,17)50.02,
p> .05] (data not shown).
4 | DISCUSSION
In previous work, we found that systemic injections of the CRF1 recep-
tor antagonist R121919 or intra-BNST administration of the CRF
receptor antagonist D-Phe-CRF(12–41) selectively decreased frustration
stress-induced binge eating in female rats with a history of food restric-
tion. These compounds did not affect palatable food intake in control
rats (Micioni Di Bonaventura et al., 2014).
It is known that binge eating is also associated with stimulation of
HPA axis activity and elevation of peripheral corticosteroids (Artiga
et al., 2007; Cifani et al., 2010; Cifani et al., 2009). Activation of CRF1
receptors in the PVN is a primary mechanism responsible for HPA axis
FIGURE 2 Systemic injection of corticosterone failed to elicit binge eating. (a) Mean6 SEM palatable food intake during the first 15 min
(left) and the cumulative 2 h (right) test session. #p< .05; ##p< .01, different from the other two vehicle groups. n56–8 per group. (b)
Mean6SEM palatable food intake during the first 15 min (left) and the cumulative 2 h (right) test session. #p<0.05; ##p< .01, different
from the nonrestricted and nonstressed group. n56–8 per group
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activation by stress, whereas at extrahypothalamic sites (i.e., BNST,
CeA, BLA, etc) CRF1 modulates affective and emotional reactions.
We sought therefore, importantly, to determine whether the effect
of CRF1 receptor antagonist on binge eating is linked to their ability to
blunt the activity of HPA axis system.
To examine this possibility, we tested the effect of metyrapone, a
corticosterone synthesis inhibitor, to inhibit binge eating, but it did not
reduce palatable food intake in any experimental group. To confirm
this finding, after three cycles of food restriction and ad libitum feed-
ing, we replaced the frustration stress with multiple concentrations of
FIGURE 3 Restricted and stressed rats showed up-regulation of crh1 receptor mRNA signal in the BNST and CeA but not in BLA or in
PVN. (a) crhr1 mRNA levels in dorsal BNST, (b) ventral BNST, (c) CeA, (d) BLA, and (e) PVN. #p< .05; ##p< .01, different from the nonres-
tricted and nonstressed group. n56 per group
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corticosterone, but it failed to elicit binge eating. Taken together, these
findings do not support a critical role for HPA axis in the expression of
this food-related maladaptive behavior in female rats. Then we focused
our attention to the regulation of CRF1 receptors at extrahypothalamic
sites: we determined expression of the crhr1 mRNA in restricted and
stressed rats showing binge-eating behavior or their controls. Data
revealed a significant up-regulation of crhr1 mRNA levels in the dorsal
portion of the BNST and in the CeA only in restricted and stressed
rats, whereas no changes were detected in the BLA and in the PVN in
any groups of rats.
Lack of changes in the PVN provides a further confirmation for a
limited role of hypothalamic CRF1 receptor mediated mechanisms in
binge-eating expression, whereas it is extremely interesting to observe
over expression of the of crhr1 transcripts both in the BNST and CeA.
Considering these in situ hybridization data, nonselective CRF receptor
antagonist D-Phe-CRF(12–41) was administered into the CeA and the
BLA. Blockade of CRF receptors in the CeA decreased binge eating in
restricted and stressed rats, whereas no effect was detected in the
BLA. In this work we focused on the amygdala, because we already
reported the important role of BNST in the expression of binge eating
(Micioni Di Bonaventura et al., 2014): we found an enhancement of c-
fos levels in binge female rats in this brain region and the D-Phe-
CRF(12–41) administration completely blocked this behavior selectively
in restricted and stressed rats.
The amygdala and BNST are brain regions anatomically and func-
tionally connected (de Olmos & Heimer, 1999) and the amygdala is
known to have CRF-containing projection to the BNST (Erb, Salmaso,
Rodaros, & Stewart, 2001) and in particular CeA has emerged as an
important area in the regulation of excessive consumption of palatable
food (Blasio et al., 2013; de Olmos & Heimer, 1999; Iemolo et al.,
2013; Micioni Di Bonaventura et al., 2017). The observation that block-
ade of CRF receptors in these brain areas completely reversed stress-
induced binge eating in our model indicates a critical role of extrahypo-
thalamic CRF systems. Moreover, both CRF antagonists tested, cen-
trally and peripherally injected, selectively blocked frustration stress-
induced binge eating after a history of food restriction, without affect-
ing only stressed or only restricted rats.
In this regard, it is also important to consider that the effect of
CRF1 receptor antagonism on binge eating, appears to be unrelated
to the regulation of satiety mechanism or caloric intake, as we
detected an effect only when consumption was triggered by stress
and associated with a loss of control. This finding is in agreement
with Parylak et al. (2012) report, showing that systemic injections of
R121919 has no effect on binge-like eating in female rats not
exposed to stress in a different binge-eating model (Parylak, Cot-
tone, Sabino, Rice, & Zorrilla, 2012). Taking into account this selec-
tive effect, it is also possible to exclude with these compounds and
these doses malaise and taste aversion, that CRF antagonism can
produce (Heinrichs et al., 1998) and influence satiety or feeding
behavior per se.
This work extends to our previous results on the role of CRF
receptors and supports further investigation to understand how CRF
antagonists block feeding consumption in different animal conditions,
such as intermittent access to chocolate flavored, high-sucrose diet
(Cottone et al., 2009), or reduce stress-induced reinstatement of palat-
able food seeking (Ghitza et al., 2006).
Moreover, in humans, promising anti-craving properties were
exhibited in the presence of the CRF1 antagonist, pexacerfont,
FIGURE 4 Injection D-Phe-CRF(12–41) in CeA blocked binge-like eating behavior. Mean6 SEM palatable food intake during the first 15 min
(left) and the cumulative 2 h (right) test session. **p< .01, different from the vehicle condition #p< .05; ##p< .01, different from the other
vehicle groups. n55–6 per group
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especially in the presence of palatable food in restrained eaters (Gold,
Frost-Pineda, & Jacobs, 2003). Unfortunately, this clinical study was
interrupted because of only an administrative interpretation of US fed-
eral law and not for the course of study.
In conclusion, the results of the present study do not support a
direct role of the HPA axis and corticosterone in the expression of
binge eating in female rats. Eating disorders share important common-
alities with substance abuse (Avena et al., 2011; Shepard, Barron, &
Myers, 2000), for example, high circulating levels of glucocorticoids can
sensitize the CRF systems in extrahypothalamic sites such as the CeA
and norepinephrine systems in the BLA, that are known to be involved
in behavioral responses to stressors (Imaki, Nahan, Rivier, Sawchenko,
& Vale, 1991; Shepard et al., 2000). Thus, it may be hypothesized that
activation of the HPA axis may lead to subsequent activation of extra-
hypothalamic brain stress systems, as described for drug addiction
(Koob & Le Moal, 2005; Koob & Kreek, 2007; Kreek & Koob, 1998),
and that CRF1 receptors may be involved in these effects.
5 | CONCLUSION
The findings of the present study provide clear evidence that CRF is
involved in the binge-eating response to stress and food restrictions in
female rats, and the crucial role of CRF receptors in BNST and CeA;
this effect may be related to extrahypothalamic effects of CRF and
CRF1 receptor antagonists may represent interesting tools for the
pharmacotherapy of binge-eating related disorders.
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